-
Follow Us On:
-
-
Implantable Cardioverter Defibrillators, or ICDs, are placed in patients at risk of life-threatening fast heart rhythms so the device can detect and treat them immediately.
The device continuously monitors the heart rhythm and responds when dangerous ventricular rhythms occur.
Implantation is planned after careful assessment of heart function, prior rhythm events, and future risk.
ICDs can provide pacing, anti-tachycardia therapy, and shock treatment when required.
Regular device review is essential to confirm settings, battery life, and event recordings.
Patients with documented ventricular tachycardia or survivors of sudden cardiac arrest.
People with severely reduced heart function who remain at high arrhythmic risk.
Patients with inherited or structural heart disorders linked to dangerous fast rhythms.
Cases where long-term rhythm protection is needed beyond medicine alone.
Patients with repeated serious rhythm events or strong risk markers on cardiac evaluation.
Individuals whose heart muscle weakness places them at elevated sudden death risk.
People needing continuous rhythm surveillance and emergency device therapy.
Patients who require specialist guidance for long-term device-based prevention.
Supports timely treatment before circulation or heart function worsens.
Can improve symptoms, daily comfort, and overall recovery planning.
Helps reduce the risk of future cardiac or vascular complications.
Offers a structured path toward safer follow-up and better long-term outcomes.
Consult our cardiology team to understand whether Implantable Cardioverter Defibrillators - ICD is right for your condition. Timely planning helps improve treatment outcomes, reduce complications, and support smoother recovery and follow-up.
Implantable Cardioverter Defibrillators, or ICDs, are placed in patients at risk of life-threatening fast heart rhythms so the device can detect and treat them immediately. The device continuously monitors the heart rhythm and responds when dangerous ventricular rhythms occur. Implantation is planned after careful assessment of heart function, prior rhythm events, and future risk. ICDs can provide pacing, anti-tachycardia therapy, and shock treatment when required. Regular device review is essential to confirm settings, battery life, and event recordings.
Patients with documented ventricular tachycardia or survivors of sudden cardiac arrest. People with severely reduced heart function who remain at high arrhythmic risk. Patients with inherited or structural heart disorders linked to dangerous fast rhythms. Cases where long-term rhythm protection is needed beyond medicine alone.
Patients with repeated serious rhythm events or strong risk markers on cardiac evaluation. Individuals whose heart muscle weakness places them at elevated sudden death risk. People needing continuous rhythm surveillance and emergency device therapy. Patients who require specialist guidance for long-term device-based prevention.
Supports timely treatment before circulation or heart function worsens. Can improve symptoms, daily comfort, and overall recovery planning. Helps reduce the risk of future cardiac or vascular complications. Offers a structured path toward safer follow-up and better long-term outcomes.